StockData
DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc. (DMAC) stock

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$8.38+0.05 (+0.60%)

Close on Nov 17, 2026Market cap $451.90MP/E –Yield –

Earnings

DiaMedica Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 30, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q1 FY2026
–
EPS, Q1 FY2026
-$0.19
-$0.18 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of DiaMedica Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 30, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close–––Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026during market hours–––Release
Q1 FY2026ended Mar 31, 2026May 6, 2026during market hours––-$0.19Release
Q4 FY2025ended Dec 31, 2025Mar 31, 2026during market hours–––Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025during market hours–––Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025during market hours––-$0.18Release
Q1 FY2025ended Mar 31, 2025May 13, 2025during market hours––-$0.18Release
Q4 FY2024ended Dec 31, 2024Mar 17, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024during market hours–––Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024during market hours––-$0.13Release
Q1 FY2024ended Mar 31, 2024May 8, 2024during market hours––-$0.14Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

DiaMedica Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When DiaMedica Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases DiaMedica Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Update
  6. Results
  7. Results
  8. Update
  9. News
  10. Update
  11. Update
  12. Results
  13. Results
  14. Update
  15. Results

See a number that looks wrong?